Using a CO2 rebreather to improve blood pressure in patients with neurogenic orthostatic hypotension
Official title: CO2 Rebreathing to Increase Blood Pressure in Neurogenic Orthostatic Hypotension: A Proof-of-Concept Pilot Study
Run by University of Calgary · NCT05908760 · Data updated 2026-11-12
This study is testing whether a CO2 rebreather can help people with neurogenic orthostatic hypotension improve their blood pressure and feel better when standing up.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 28 (estimated) |
| Sponsor | University of Calgary Academic / other |
| Locations | 1 site (Calgary, Alberta) |
| Status | Recruiting |
| Started | July 30, 2024 |
| Main results expected | December 31, 2029 |
| Study ends | December 31, 2030 |
| Registry record updated | May 5, 2026 |
| Trial ID | NCT05908760 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older with a physician diagnosis of neurogenic orthostatic hypotension.
✕Probably not a fit
Patients with chronic heart failure, severe pulmonary disease, or other systemic illnesses affecting autonomic function may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study evaluates the effectiveness of a CO2 rebreather device in improving blood pressure and orthostatic tolerance in patients diagnosed with neurogenic orthostatic hypotension (nOH). The study is based on the hypothesis that increasing arterial CO2 levels through rebreathing can enhance blood pressure responses in these patients. The intervention involves capturing and re-inhaling expired CO2 to transiently elevate CO2 levels, potentially offering a novel treatment approach for managing nOH symptoms. The study will include 28 participants who meet specific eligibility criteria and will be conducted at the University of Calgary.
Why it matters
Potential benefit: If successful, this approach could significantly improve blood pressure regulation and quality of life for patients suffering from neurogenic orthostatic hypotension.
How similar studies have gone: While this approach is novel, previous studies have indicated that hypercapnia can improve blood pressure in patients with nOH, suggesting potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years * Male and Female * Physician diagnosis of Neurogenic Orthostatic Hypotension * Non-smokers. * Able and willing to provide informed consent. * Ability to travel to Libin Cardiovascular Institute Autonomic Testing Lab at the University of Calgary, Calgary, AB. Exclusion Criteria: * Medical therapies or medications which could interfere with testing of autonomic function * Pregnant or breast-feeding females * Subjects with chronic heart failure or severe pulmonary disease who are unable to climb one flight of stairs due to shortness of breath. * Presence of failure of other organ systems or systemic illness that can affect autonomic function or the participant's ability to cooperate. These include dementia, alcohol and/or drug abuse, cerebrovascular disease, kidney or liver disease, surgical procedures where the nerves of the sympathetic nervous system have been cut. * Other factors which in the investigator's opinion would prevent the participant from completing the protocol, including poor compliance during previous studies.
Where it's running
-
University of Calgary
Calgary, Alberta, Canada Recruiting
Study contacts
- Principal investigator: Satish R Raj, MD — University of Calgary
- Study coordinator: Jacquie Baker, PhD
- Email: autonomic.research@ucalgary.ca
- Phone: 4032103819
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using CPAP to treat high blood pressure in patients with autonomic failure
This study tests if using a CPAP machine can help people with autonomic failure lower their nighttime blood pressure when they lie down.
-
Breathing carbon dioxide to help with low blood pressure when standing
This study tests if breathing in carbon dioxide can help people with Neurogenic Orthostatic Hypotension feel better and manage their blood pressure when standing.
-
Using an accelerometer to measure symptoms of neurogenic orthostatic hypotension
This study is testing if using a device to track how long people with neurogenic orthostatic hypotension can stay upright helps show if their medication works better than a placebo.
-
Raising the head of the bed to lower blood pressure in patients with autonomic failure
This study is testing if raising the head of the bed can help people with autonomic failure lower their high blood pressure while lying down.
-
Imaging with [18F]F-DOPA in patients with autonomic failure
This study is testing a special imaging technique to see if it can help identify early signs of neurodegenerative diseases in people with autonomic failure.
-
Using CPAP to treat high blood pressure in patients with autonomic failure
This study tests if using a CPAP machine at night can help lower blood pressure in patients with autonomic failure who have high blood pressure when lying down.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.